HepTcell

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
HepTcell Immunotherapy in Patients With Inactive Chronic Hepatitis B (CHB)NCT04684914ALTPhase 2Terminated2024-03-27Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.